A Study of the Real-life Management of Psoriasis Patients Treated With Otezla® (Apremilast) in Belgium
Clinical trial NCT03097003 · COMPLETED
Trial details
- NCT number
- NCT03097003
- Sponsor
- Amgen
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2017-04-06
- Primary completion
- 2018-12-20
- Enrollment
- 124
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.